Trial Profile
The penetration of moxifloxacin (BAY 12-8039) into the excretory pancreatic secret after intravenous application.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Jun 2018
Price :
$35
*
At a glance
- Drugs Moxifloxacin (Primary) ; Moxifloxacin (Primary)
- Indications Bacterial infections; Pancreatitis
- Focus Pharmacokinetics
- 08 Sep 2011 New trial record